WuXi PharmaTech Price Target Raised to $42.00 at Jefferies Group (WX)
Stock analysts at Jefferies Group boosted their target price on shares of WuXi PharmaTech (NYSE:WX) from $38.00 to $42.00 in a report issued on Tuesday, AnalystRatingsNetwork reports. Jefferies Group’s target price points to a potential upside of 11.64% from the stock’s previous close.
WuXi PharmaTech (NYSE:WX) traded up 4.70% on Tuesday, hitting $37.62. 1,016,987 shares of the company’s stock traded hands. WuXi PharmaTech has a 52-week low of $15.73 and a 52-week high of $38.69. The stock has a 50-day moving average of $34.37 and a 200-day moving average of $27.63. The company has a market cap of $2.679 billion and a P/E ratio of 24.93.
WuXi PharmaTech (NYSE:WX) last issued its quarterly earnings data on Wednesday, November 13th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.08. The company had revenue of $146.70 million for the quarter, compared to the consensus estimate of $145.29 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. Analysts expect that WuXi PharmaTech will post $1.75 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on WX. Analysts at Oppenheimer raised their price target on shares of WuXi PharmaTech from $32.00 to $38.00 in a research note to investors on Thursday, November 14th. They now have an “outperform” rating on the stock. Separately, analysts at Janney Montgomery Scott raised their price target on shares of WuXi PharmaTech from $28.00 to $31.00 in a research note to investors on Thursday, November 14th. They now have a “neutral” rating on the stock. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $26.26.
WuXi PharmaTech (NYSE:WX) Inc, (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in People’s Republic of China and the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.